Literature DB >> 27708977

Kaposi's sarcoma concurrent with granulomatosis polyangiitis.

Diler Taş Kılıç1, Selma Karaahmetoğlu Özkan1, Başol Canbakan1, Nesrin Dündar1.   

Abstract

Kaposi's sarcoma (KS), a malignant vascular tumor, can develop in patients who receive corticosteroids or immunosuppressive therapy. We report a patient with KS and granulomatosis polyangiitis (GPA). To the best of our knowledge, this is the first report regarding the co-occurrence of these two diseases. The physician must be aware of the risk of cancer in patients with rheumatism.

Entities:  

Keywords:  Kaposi sarcoma; granulomatous poliangiitis; vasculitis

Year:  2015        PMID： 27708977      PMCID： PMC5042236          DOI： 10.5152/eurjrheum.2015.0027

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


  11 in total

1.  Kaposi's sarcoma in an elderly man with Wegener's granulomatosis treated with cyclophosphamide and corticosteroids.

Authors:  S B Erban; R K Sokas
Journal:  Arch Intern Med       Date:  1988-05

2.  Development of multiple malignancies after immunosuppression in a patient with Wegener's granulomatosis.

Authors:  Mari Hoff; Erik Rødevand
Journal:  Rheumatol Int       Date:  2005-01-20       Impact factor: 2.631

3.  Kaposi's sarcoma.

Authors:  Cornelus J G Sanders; Marijke R Canninga-van Dijk; Jan C Borleffs
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

4.  Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta.

Authors:  J Cai; T Zheng; M Lotz; Y Zhang; R Masood; P Gill
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

5.  Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.

Authors:  S Marinaki; I Neumann; A-I Kälsch; P Grimminger; A Breedijk; R Birck; W Schmitt; R Waldherr; B A Yard; F J Van Der Woude
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 6.  Kaposi's sarcoma in rheumatic diseases.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Pongsak Mahanuphab; Lertlakana Bhoopat; Sumitra Thongprasert
Journal:  Semin Arthritis Rheum       Date:  2003-04       Impact factor: 5.532

7.  Malignancy risk in vasculitis.

Authors:  Tanaz A Kermani; Kenneth J Warrington; Shreyasee Amin
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

8.  Kaposi's sarcoma following immunosuppressive therapy for vasculitis.

Authors:  Tarik Bouattar; Laila Kazmouhi; Zaitouna Alhamany; Kawtar Beqqal; Laila Haffane; Tarik Sqalli Houssaini; Hakima Rhou; Loubna Benamar; Karima Senouci; Rabia Bayahia; Naima Ouzeddoun
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-03

9.  AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation.

Authors:  W X Guo; T Antakly
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

Review 10.  Cancer risk in immune-mediated inflammatory diseases (IMID).

Authors:  Rudi Beyaert; Laurent Beaugerie; Gert Van Assche; Lieve Brochez; Jean-Christophe Renauld; Manuelle Viguier; Veronique Cocquyt; Guy Jerusalem; Jean-Pascal Machiels; Hans Prenen; Pierre Masson; Edouard Louis; Filip De Keyser
Journal:  Mol Cancer       Date:  2013-08-29       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.